A matched-pair analysis of dose-escalated adaptive image-guided radiotherapy (IGRT) versus pelvic irradiation with brachytherapy boost for intermediate- and high-risk prostate cancer

被引：0
|
作者：
Shah, C.
Kestin, L. L.
Ghilezan, M.
Vicini, F. A.
Gustafson, G. S.
Brabbins, D.
Wallace, M.
Marvin, K.
Ye, H.
Martinez, A.
机构：
[1] William Beaumont Hosp, Royal Oak, MI 48072 USA
[2] William Beaumont Hosp, Troy, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.71
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
71
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Potential applications of image-guided radiotherapy for radiation dose escalation in patients with early stage high-risk prostate cancer
    Nguyen, Nam P.
    Davis, Rick
    Bose, Satya R.
    Dutta, Suresh
    Vinh-Hung, Vincent
    Chi, Alexander
    Godinez, Juan
    Desai, Anand
    Woods, William
    Altdorfer, Gabor
    D'Andrea, Mark
    Karlsson, Ulf
    Vo, Richard A.
    Sroka, Thomas
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [42] Impact of rotational errors of whole pelvis on the dose of prostate-based image-guided radiotherapy to pelvic lymph nodes and small bowel in high-risk prostate cancer
    Katayama, Hiroki
    Takahashi, Shigeo
    Kobata, Takuya
    Oishi, Akihiro
    Shibata, Toru
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2021, 26 (06) : 906 - 914
  • [43] An Updated Analysis of Survival Endpoints for ASCENDE-RT, a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
    Oh, J.
    Tyldesley, S.
    Pai, H. H.
    McKenzie, M. R.
    Halperin, R. M.
    Duncan, G. G.
    Morton, G.
    Keyes, M.
    Hamm, J.
    Morris, W. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S62 - S62
  • [44] AN UPDATED ANALYSIS OF SURVIVAL ENDPOINTS FOR ASCENDE-RT, A RANDOMIZED TRIAL COMPARING A LOW-DOSE-RATE BRACHYTHERAPY BOOST TO A DOSE-ESCALATED EXTERNAL BEAM BOOST FOR HIGH- AND INTERMEDIATE-RISK PROSTATE CANCER
    Oh, Justin
    Tyldesley, Scott
    Pai, Howard
    McKenzie, Michael
    Halperin, Ross
    Duncan, Graeme
    Morton, Gerard
    Keyes, Mira
    Hamm, Jeremy
    Morris, James
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S9 - S9
  • [45] Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life
    Musunuru, Hima Bindu
    Cheung, Patrick
    Vesprini, Danny
    Liu, Stanley K.
    Chu, William
    Chung, Hans T.
    Morton, Gerard
    Deabreu, Andrea
    Davidson, Melanie
    Ravi, Ananth
    Helou, Joelle
    Ho, Ling
    Zhang, Liying
    Loblaw, Andrew
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : 40 - 46
  • [46] Stereotactic body radiotherapy (SBRT) versus high dose rate (HDR) brachytherapy (BT) boost for high-risk (HR) prostate cancer.
    Gonzalez-Motta, Alejandro
    Roach, Mack
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [47] Combined HDR brachytherapy boost plus external beam radiotherapy by IMRT versus external beam radiotherapy alone IMRT in intermediate- and high-risk prostate cancer: Dosimetric analysis from a randomized control trial.
    Annamalai, Manikandan
    Ma, Laviraj
    Kunhiparambath, Haresh
    Sharma, Dayanand
    Gupta, Subhash
    Mallick, Supriya
    Julka, Pramod Kumar
    Rath, Goura Kishor
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [48] Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
    Wei Guo
    Yun-Chuan Sun
    Jian-Qiang Bi
    Xin-Ying He
    Li Xiao
    BMC Cancer, 19
  • [49] Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
    Guo, Wei
    Sun, Yun-Chuan
    Bi, Jian-Qiang
    He, Xin-Ying
    Xiao, Li
    BMC CANCER, 2019, 19 (01)
  • [50] ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High-and Intermediate-Risk Prostate Cancer
    Rodda, Sree
    Tyldesley, Scott
    Morris, W. James
    Keyes, Mira
    Halperin, Ross
    Pai, Howard
    McKenzie, Michael
    Duncan, Graeme
    Morton, Gerard
    Hamm, Jeremy
    Murray, Nevin
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : 286 - 295
12345